US drug approvals
2 approvals with a product on the US market
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
- 0Reports naming them
- 3Markets in public records
- 0Regions & countries
- See reportsGrowth in full reports
Free public data on Formycon AG
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on openFDA (opens in a new tab)
Markets where public records show them
Markets we cover where free public records show Formycon AG: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Formycon AG is in.
From our blog
Stories on the topics Formycon AG works in.
Eye Health Supplements: Screens, Ageing and Vision
2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a…
Read
Wound Care: Advanced Dressings for Faster Healing
Nearly 15% of US Medicare beneficiaries, 8.2 million people, had a wound or wound infection in one year…
Read
Insulin Delivery Devices: Pens, Pumps and Beyond
Over 9.5 million people live with type 1 diabetes and need insulin every day. How delivery devices are…
Read